Your browser doesn't support javascript.
loading
Conjugation of VEGFR1/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity.
Zanjanchi, Pegah; Asghari, S Mohsen; Mohabatkar, Hassan; Shourian, Mostafa; Shafiee Ardestani, Mehdi.
Affiliation
  • Zanjanchi P; Department of Biotechnology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, 8174673441, Iran.
  • Asghari SM; Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, 1417614411, Iran. sm.asghari@ut.ac.ir.
  • Mohabatkar H; Department of Biotechnology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, 8174673441, Iran. h.mohabatkar@ast.ui.ac.ir.
  • Shourian M; Department of Biology, Faculty of Sciences, University of Guilan, Rasht, 4199613776, Iran.
  • Shafiee Ardestani M; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
J Nanobiotechnology ; 20(1): 7, 2022 Jan 04.
Article in En | MEDLINE | ID: mdl-34983556
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiogenesis Inhibitors / Vascular Endothelial Growth Factor Receptor-1 / Vascular Endothelial Growth Factor Receptor-2 / Metal Nanoparticles / Gold Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Nanobiotechnology Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiogenesis Inhibitors / Vascular Endothelial Growth Factor Receptor-1 / Vascular Endothelial Growth Factor Receptor-2 / Metal Nanoparticles / Gold Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Nanobiotechnology Year: 2022 Document type: Article Affiliation country: Country of publication: